Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 3/20 | 0.56 |
| ▸ | NOS3 | P29474 | 1/20 | 0.56 |
| ▸ | NOS2 | P35228 | 1/20 | 0.56 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.55 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.55 |
| ▸ | GRIK1 | P39086 | 6/20 | 0.53 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.53 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.46 |
| ▸ | GSR | P00390 | 2/20 | 0.44 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | GRM8 | O00222 | 1/20 | 0.42 |
| ▸ | GRM6 | O15303 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4853808 | 1.00 | NOS1 (0.56) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL516471 | 0.93 | GRIK1 (0.57) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL8063263 | 0.91 | GSR (0.52) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL21952409 | 0.88 | NOS1 (0.59) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL20751441 | 0.88 | NOS1 (0.59) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL21335891 | 0.85 | GSR (0.48) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL25660613 | 0.83 | NOS3 (0.54) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL2757451 | 0.82 | NOS3 (0.54) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL5607813 | 0.82 | NOS3 (0.54) | NOS1NOS3NOS2SLC1A2SLC1A1 | |
| SCHEMBL25660616 | 0.82 | NOS3 (0.57) | NOS1NOS3NOS2SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | claimed |
| WO-2004021981-A2 | METHODS FOR THE PREPARATION OF β-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-18 | — | — | WO | claimed |
| US-20030113882-A1 | Methods for the preparation of beta-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-06-19 | — | — | US | claimed |
| EP-4724459-A1 | PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | Peptidream Inc (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-4724457-A2 | RADIOPHARMACEUTICAL COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | Rayzebio, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024254339-A9 | RADIOPHARMACEUTICAL COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | RAYZEBIO, INC. (US) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025070731-A1 | PEPTIDEPEPTIDE | ペプチドリーム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2025070720-A1 | PEPTIDE | ペプチドリーム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2024254339-A2 | RADIOPHARMACEUTICAL COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | RAYZEBIO, INC. (US) | 2024-12-12 | — | — | WO | disclosed |
| WO-2024252336-A1 | PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | PEPTIDREAM INC. (JP) | 2024-12-12 | — | — | WO | disclosed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
| CN-102471489-B | Supermolecule polymer and the compositions comprising described polymer | 罗地亚经营管理公司 | 2016-08-03 | — | — | CN | disclosed |
| US-9012567-B2 | Supramolecular polymers and compositions containing said polymers | RHODIA OPERATIONS (FR) | 2015-04-21 | — | — | US | disclosed |
| US-20120289652-A1 | SUPRAMOLECULAR POLYMERS AND COMPOSITIONS CONTAINING SAID POLYMERS | RHODIA OPERATIONS (FR) | 2012-11-15 | — | — | US | disclosed |
| CN-102471489-A | Supramolecular polymers and compositions comprising said polymers | RHODIA OPERATIONS | 2012-05-23 | — | — | CN | disclosed |
| US-7452701-B2 | Methods for the preparation of β-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-11-18 | — | — | US | disclosed |
| WO-2004021981-A2 | METHODS FOR THE PREPARATION OF β-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20030113882-A1 | Methods for the preparation of beta-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | NOS1 1488/4885NOS3 1214/4885NOS2 880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.